当前位置：首页 > 文献互助 > 互助详情

期刊论文 Trial of the Oral PCSK9 Inhibitor Enlicitide. Reply复制

用户wxb8loTerxGI 16分钟前 8 求助中帖子自动结束时间: 2026-05-31 11:20:53

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

AM Navar, AL Catapano…
The New England …, 2026
pubmed.ncbi.nlm.nih.gov

互助时间线

Hydrophilic nano-SiO2/PVA-based coating with durable antifogging properties 8分钟前

Trial of the Oral PCSK9 Inhibitor Enlicitide. Reply 16分钟前

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2026 American College of Cardiology Conference 17分钟前

Oral epinastine vs loratadine in seasonal allergic rhinitis: A randomized, double‑blind, placebo‑controlled trial 19分钟前

Mining of adverse event signals associated with inclisiran: a post-marketing analysis based on FAERS 22分钟前

Phase 3 study results for oral PCSK9 inhibition with enlicitide 22分钟前

Epinastine: An update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases. 31分钟前

Enantioselective Copper-Catalyzed Construction of Aryl Pyrroloindolines via an Arylation–Cyclization Cascade 33分钟前

Intratonsillar Immunotherapy: A Convenient and Effective Alternative to Subcutaneous Immunotherapy for Allergic Rhinitis 41分钟前